These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1515 related items for PubMed ID: 19161414

  • 1. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A, Picard C, Abel L, Jouanguy E, Casanova JL.
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [Abstract] [Full Text] [Related]

  • 2. Human primary immunodeficiencies of type I interferons.
    Jouanguy E, Zhang SY, Chapgier A, Sancho-Shimizu V, Puel A, Picard C, Boisson-Dupuis S, Abel L, Casanova JL.
    Biochimie; 2007 Dec; 89(6-7):878-83. PubMed ID: 17561326
    [Abstract] [Full Text] [Related]

  • 3. Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases.
    Bustamante J, Boisson-Dupuis S, Jouanguy E, Picard C, Puel A, Abel L, Casanova JL.
    Curr Opin Immunol; 2008 Feb; 20(1):39-48. PubMed ID: 18083507
    [Abstract] [Full Text] [Related]

  • 4. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N, Deacon PM, Lichty B, Mossman KL, Ashkar AA.
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [Abstract] [Full Text] [Related]

  • 5. Role of IFN-alpha/beta signaling in the prevention of genital herpes virus type 2 infection.
    Svensson A, Bellner L, Magnusson M, Eriksson K.
    J Reprod Immunol; 2007 Jun; 74(1-2):114-23. PubMed ID: 17092567
    [Abstract] [Full Text] [Related]

  • 6. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features.
    Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, Jouanguy E, Boisson-Dupuis S, Fieschi C, Picard C, Casanova JL.
    Semin Immunol; 2006 Dec; 18(6):347-61. PubMed ID: 16997570
    [Abstract] [Full Text] [Related]

  • 7. Control of human host immunity to mycobacteria.
    Ottenhoff TH, Verreck FA, Hoeve MA, van de Vosse E.
    Tuberculosis (Edinb); 2005 Dec; 85(1-2):53-64. PubMed ID: 15687028
    [Abstract] [Full Text] [Related]

  • 8. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.
    Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, Al-Jumaah S, Yang K, Chapgier A, Eidenschenk C, Eid P, Al Ghonaium A, Tufenkeji H, Frayha H, Al-Gazlan S, Al-Rayes H, Schreiber RD, Gresser I, Casanova JL.
    Nat Genet; 2003 Mar; 33(3):388-91. PubMed ID: 12590259
    [Abstract] [Full Text] [Related]

  • 9. Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans.
    Sancho-Shimizu V, Zhang SY, Abel L, Tardieu M, Rozenberg F, Jouanguy E, Casanova JL.
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):495-505. PubMed ID: 17989525
    [Abstract] [Full Text] [Related]

  • 10. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection.
    Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC, Morinobu A, Gadina M, O'Shea JJ, Biron CA.
    Science; 2002 Sep 20; 297(5589):2063-6. PubMed ID: 12242445
    [Abstract] [Full Text] [Related]

  • 11. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.
    Ottenhoff TH, Verreck FA, Lichtenauer-Kaligis EG, Hoeve MA, Sanal O, van Dissel JT.
    Nat Genet; 2002 Sep 20; 32(1):97-105. PubMed ID: 12205477
    [Abstract] [Full Text] [Related]

  • 12. [In vitro and in vivo inhibition of HIV1 replication by retroviral transfer of interferon alpha, beta, or gamma genes: application to gene therapy of AIDS].
    Leissner P, Calenda V, Marigliano M, Sanhadji K, Touraine JL, Pavirani A, Mehtali M.
    Ann Biol Clin (Paris); 1998 Sep 20; 56(2):167-73. PubMed ID: 9754242
    [Abstract] [Full Text] [Related]

  • 13. Inborn errors of anti-viral interferon immunity in humans.
    Sancho-Shimizu V, Perez de Diego R, Jouanguy E, Zhang SY, Casanova JL.
    Curr Opin Virol; 2011 Dec 20; 1(6):487-96. PubMed ID: 22347990
    [Abstract] [Full Text] [Related]

  • 14. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections.
    Biron CA.
    Semin Immunol; 1998 Oct 20; 10(5):383-90. PubMed ID: 9799713
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3.
    Hato SV, Ricour C, Schulte BM, Lanke KH, de Bruijni M, Zoll J, Melchers WJ, Michiels T, van Kuppeveld FJ.
    Cell Microbiol; 2007 Dec 20; 9(12):2921-30. PubMed ID: 17991048
    [Abstract] [Full Text] [Related]

  • 18. Interferons, interferon-like cytokines, and their receptors.
    Pestka S, Krause CD, Walter MR.
    Immunol Rev; 2004 Dec 20; 202():8-32. PubMed ID: 15546383
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.
    Sakurai F, Terada T, Maruyama M, Watanabe Y, Yamashita F, Takakura Y, Hashida M.
    Cancer Gene Ther; 2003 Sep 20; 10(9):661-8. PubMed ID: 12944985
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous production of IFN-gamma, IFN-alpha/beta and nitric oxide in peritoneal macrophages from TDM-treated mice.
    Guillemard E, Geniteau-Legendre M, Kergot R, Lemaire G, Gessani S, Labarre C, Quero AM.
    J Biol Regul Homeost Agents; 1998 Sep 20; 12(4):106-11. PubMed ID: 10022001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.